Lataa...
Randomized immunotherapy trial in dual‐allergic patients using “active allergen placebo” as control
BACKGROUND: Placebo control in allergen immunotherapy (AIT) trials presents ethical and blinding concerns. We tested a trial design with an “active allergen placebo,” as proposed by ARIA‐GA (2) LEN, to investigate in a double‐blind trial the efficacy and safety of AIT in dual‐allergic patients (gras...
Tallennettuna:
| Julkaisussa: | Allergy |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6773203/ https://ncbi.nlm.nih.gov/pubmed/31025363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.13842 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|